IP Library Granted Patent US 12,336,713
Granted Patent B2
US 12,336,713 · App. 18/764,537 · Granted Jun 24, 2025

Surgical staples comprising hardness variations for improved fastening of tissues

Inventors: Frederick E. Shelton, IV (Hillsboro, OH); Jeffrey S. Swayze (West Chester, OH); Chester O. Baxter, III (Loveland, OH)
Assignee: Cilag GmbH International
A61B17/105A61B17/0469A61B17/064A61B17/0644A61B17/068A61B17/072A61B17/07207A61B17/07292A61B17/115A61B17/1155A61B17/32A61L31/022A61L31/10A61L31/148A61B2017/00004A61B2017/00398A61B17/00491A61B2017/00526A61B2017/00831A61B2017/00889A61B2017/00893A61B2017/00964A61B17/0401A61B2017/0464A61B2017/0472A61B2017/06042A61B2017/0645A61B2017/07214A61B2017/07221A61B2017/07228A61B2017/07235A61B2017/07242A61B2017/07264A61B2017/07271A61B2017/07278A61B2017/1142A61B2017/2929A61B2017/320052A61B2090/037A61B2090/038A61B2090/08021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,336,713
App. No.
18/764,537
Granted
Jun 24, 2025
Kind
B2
Abstract

A surgical staple cartridge is disclosed comprising a plurality of staples removably stored within the surgical staple cartridge. The staples comprise staple legs which extend from a staple base portion. The staple legs comprise staple tips configured to pierce tissue and contact a corresponding forming pocket of an anvil of surgical stapling instrument. The staples further comprise zones having different hardnesses.

Claims (34)

1. A surgical staple, comprising:

(a) a bioabsorbable frame including a crown and a pair of legs integrally connected with the crown; and

(b) a bioabsorbable coating disposed on the bioabsorbable frame such that a first portion of each leg includes the bioabsorbable coating and a second portion of each leg omits the bioabsorbable coating, wherein the bioabsorbable coating is configured to delay bioabsorption of the bioabsorbable frame when the surgical staple is implanted in tissue.

2. The surgical staple of claim 1 , wherein each of the legs terminates at a tip, wherein the bioabsorbable coating is absent on the tips and is present on a remainder of the bioabsorbable frame.

3. The surgical staple of claim 1 , wherein the bioabsorbable coating comprises a bioabsorbable polymer.

4. The surgical staple of claim 3 , wherein the bioabsorbable polymer comprises at least one of polylactic acid (PLA) or polyglycolic acid (PGA).

5. The surgical staple of claim 1 , further comprising an anti-microbial material.

6. The surgical staple of claim 5 , wherein the anti-microbial material comprises triclosan.

7. The surgical staple of claim 1 , wherein the bioabsorbable frame comprises a magnesium alloy.

8. A surgical staple assembly, comprising:

(a) the surgical staple of claim 1 , wherein each of the legs terminates at a tip; and

(b) an adjunct through which the legs of the staple are configured to extend when the staple is applied to tissue, wherein the adjunct is configured to reside between the crown and the tips of the staple when the legs are formed in the tissue.

9. The surgical staple assembly of claim 8 , wherein the adjunct is at least one of resilient or bioabsorbable.

10. The surgical staple assembly of claim 8 , further comprising an anti-microbial coating disposed on at least one of the adjunct or the surgical staple.

11. A surgical staple cartridge, comprising:

(a) a cartridge body including a deck and a plurality of staple cavities defined in the deck; and

(b) a plurality of staples disposed in the staple cavities, wherein the plurality of staples includes the surgical staple of claim 1 .

12. The surgical staple cartridge of claim 11 , in combination with an adjunct, wherein the legs of the surgical staple are configured to extend through the adjunct when the surgical staple is applied to tissue, wherein the adjunct is configured to reside between the crown and the tips of the surgical staple when the legs of the surgical staple are formed in the tissue.

13. A surgical staple, comprising:

(a) a crown;

(b) a pair of legs integrally connected with and extending away from the crown, wherein the crown and the legs are bioabsorbable; and

(c) a bioabsorbable coating disposed on the legs such that a first portion of each leg includes the bioabsorbable coating and a second portion of each leg omits the bioabsorbable coating, wherein the bioabsorbable coating is configured to delay bioabsorption of the legs when the surgical staple is implanted in tissue.

14. The surgical staple of claim 13 , wherein the crown and the legs define a bioabsorbable frame that comprises a magnesium alloy.

15. The surgical staple of claim 13 , wherein each of the legs terminates at a tip, wherein the bioabsorbable coating is omitted from the tips.

16. The surgical staple of claim 13 , wherein the bioabsorbable coating comprises at least one of polylactic acid (PLA) or polyglycolic acid (PGA).

17. The surgical staple of claim 13 , further comprising an anti-microbial coating.

18. A surgical staple assembly, comprising:

(a) a staple including:

(i) a crown,

(ii) a pair of legs integrally connected with the crown, wherein each of the legs terminates at a tip, and

(iii) a bioabsorbable coating disposed on the legs such that a first portion of each leg includes the bioabsorbable coating and a second portion of each leg omits the bioabsorbable coating; and

(b) an adjunct through which the legs of the staple are configured to extend when the staple is applied to tissue, wherein the adjunct is configured to reside between the crown and the tips of the staple when the legs are formed in the tissue.

19. The surgical staple assembly of claim 18 , wherein the crown and the legs define a bioabsorbable frame of the staple, wherein the bioabsorbable coating is configured to delay bioabsorption of the bioabsorbable frame when the staple is implanted in tissue.

20. The surgical staple assembly of claim 19 , wherein the bioabsorbable frame comprises a magnesium alloy, wherein the bioabsorbable coating comprises at least one of polylactic acid (PLA) or polyglycolic acid (PGA).

Continuity (5)
Continuation 17746488 · May 17, 2022
Continuation 17022499 · Sep 16, 2020
Continuation 16288697 · Feb 28, 2019
Continuation 14836411 · Aug 26, 2015
Related Publication 20240358373A1 · Oct 31, 2024
References Cited (96)
US 5342396A · Cook · 1994 [cited by applicant]
US 5403312A · Yates et al. · 1995 [cited by applicant]
US 6626916B1 · Yeung et al. · 2003 [cited by applicant]
US 7000818B2 · Shelton, IV et al. · 2006 [cited by applicant]
US 7422139B2 · Shelton, IV et al. · 2008 [cited by applicant]
US 7464849B2 · Shelton, IV et al. · 2008 [cited by applicant]
US 7670334B2 · Hueil et al. · 2010 [cited by applicant]
US 7721930B2 · McKenna · 2010 [cited by examiner]
US 7753245B2 · Boudreaux et al. · 2010 [cited by applicant]
US 7845537B2 · Shelton, IV et al. · 2010 [cited by applicant]
US 7980443B2 · Scheib et al. · 2011 [cited by applicant]
US 8210411B2 · Yates et al. · 2012 [cited by applicant]
US 8220688B2 · Laurent et al. · 2012 [cited by applicant]
US 8308040B2 · Huang et al. · 2012 [cited by applicant]
US 8393514B2 · Shelton, IV et al. · 2013 [cited by applicant]
US 8561870B2 · Baxter, III et al. · 2013 [cited by applicant]
US 8608045B2 · Smith et al. · 2013 [cited by applicant]
US 8733613B2 · Huitema et al. · 2014 [cited by applicant]
US 9072535B2 · Shelton, IV et al. · 2015 [cited by applicant]
US 9101358B2 · Kerr et al. · 2015 [cited by applicant]
US 9345481B2 · Hall et al. · 2016 [cited by applicant]
US D775336S · Shelton, IV et al. · 2016 [cited by applicant]
US 9549735B2 · Shelton, IV et al. · 2017 [cited by applicant]
US 9585662B2 · Shelton, IV et al. · 2017 [cited by applicant]
US 9642620B2 · Baxter, III et al. · 2017 [cited by applicant]
US 9681870B2 · Baxter, III et al. · 2017 [cited by applicant]
US 9687232B2 · Shelton, IV et al. · 2017 [cited by applicant]
US 9724092B2 · Baxter, III et al. · 2017 [cited by applicant]
US 9763662B2 · Shelton, IV et al. · 2017 [cited by applicant]
US 9839428B2 · Baxter, III et al. · 2017 [cited by applicant]
US 9968354B2 · Shelton, IV et al. · 2018 [cited by applicant]
US 10028744B2 · Shelton, IV et al. · 2018 [cited by applicant]
US 10098642B2 · Baxter, III et al. · 2018 [cited by applicant]
US 10166026B2 · Shelton, IV et al. · 2019 [cited by applicant]
US 10188394B2 · Shelton, IV et al. · 2019 [cited by applicant]
US 10213203B2 · Swayze et al. · 2019 [cited by applicant]
US 10265065B2 · Shelton, IV et al. · 2019 [cited by applicant]
US 10357251B2 · Shelton, IV · 2019 [cited by examiner]
US 10390829B2 · Eckert et al. · 2019 [cited by applicant]
US 10433845B2 · Baxter, III et al. · 2019 [cited by applicant]
US 10470769B2 · Shelton, IV et al. · 2019 [cited by applicant]
US 10517599B2 · Baxter, III et al. · 2019 [cited by applicant]
US 10966724B2 · Shelton, IV · 2021 [cited by examiner]
US 11058804B2 · Widenhouse · 2021 [cited by examiner]
US 11510675B2 · Shelton, IV · 2022 [cited by examiner]
US 11534167B2 · Diaz-Chiosa · 2022 [cited by examiner]
US 12035915B2 · Shelton, IV · 2024 [cited by examiner]
US 20020029044A1 · Monassevitch et al. · 2002 [cited by applicant]
US 20020169465A1 · Bowman et al. · 2002 [cited by applicant]
US 20040254608A1 · Huitema · 2004 [cited by examiner]
US 20060167459A1 · Groiso · 2006 [cited by applicant]
US 20060235469A1 · Viola · 2006 [cited by examiner]
US 20070175955A1 · Shelton et al. · 2007 [cited by applicant]
US 20080015598A1 · Prommersberger · 2008 [cited by applicant]
US 20080078800A1 · Hess et al. · 2008 [cited by applicant]
US 20080082126A1 · Murray · 2008 [cited by examiner]
US 20090001121A1 · Hess et al. · 2009 [cited by applicant]
US 20100331880A1 · Stopek · 2010 [cited by examiner]
US 20130041406A1 · Bear · 2013 [cited by examiner]
US 20130068815A1 · Bruewer · 2013 [cited by examiner]
US 20140166726A1 · Schellin et al. · 2014 [cited by applicant]
US 20140263552A1 · Hall et al. · 2014 [cited by applicant]
US 20150173749A1 · Shelton, IV et al. · 2015 [cited by applicant]
US 20150173756A1 · Baxter, III et al. · 2015 [cited by applicant]
US 20150173789A1 · Baxter, III et al. · 2015 [cited by applicant]
US 20170056000A1 · Nalagatla et al. · 2017 [cited by applicant]
US 20170056002A1 · Nalagatla et al. · 2017 [cited by applicant]
US 20170056005A1 · Shelton, IV et al. · 2017 [cited by applicant]
US 20220031310A1 · De La Rosa · 2022 [cited by examiner]
US 20220313264A1 · Shelton, IV et al. · 2022 [cited by applicant]
US 20220370065A1 · Shelton, IV · 2022 [cited by examiner]
CN 201617885U · 2010 [cited by applicant]
CN 103429172A · 2013 [cited by applicant]
EP 1878391A1 · 2008 [cited by applicant]
EP 2060234A1 · 2009 [cited by applicant]
EP 2886063A1 · 2015 [cited by applicant]
JP H08159124A · 1996 [cited by applicant]
JP H08507708A · 1996 [cited by applicant]
JP 2011041805A · 2011 [cited by applicant]
JP 2011078790A · 2011 [cited by applicant]
RU 94014856A · 1996 [cited by applicant]
RU 2152756C1 · 2000 [cited by applicant]
WO 2012013577A1 · 2012 [cited by applicant]
Brar, et al., “Investigation of the mechanical and degradation properties of Mg-Sr and Mg-Zn-Sr alloys for use as potential biodegradable implant materials,” J Mech Behavior of Biomed Mat, 2012, 7:87-95, 9 pgs. [cited by applicant]
Erdmann, et al., “Evaluation of the soft tissue biocompatibility of MgCa0.8 and surgical steel 316L in vivo: a comparative study in rabbits,” Biomed Eng OnLine, 2010, 9:63, 17 pgs. [cited by applicant]
Li, et al., “Mg-Zr-Sr alloys as biodegradable implant materials,” Acta Biomaterialia, 2012, 8:3177-3188, 12 pgs. [cited by applicant]
Pellicer, et al., “On the biodegradability, mechanical behavior, and cytocompatibility of amorphous Mg72Zn23Ca5 and Crystalline Mg70Zn23Ca5Pd2 alloys as temporary implant materials,” J Biomed Res, Part A, 2013, 101A:502… [cited by applicant]
Yan, et al., “Comparison of the Effects of Mg-6Zn and Ti-3Ai-2.5V Alloys on TGF-B/TNF- a/VEGF/b-FGF in the Healing of the Intestinal Tract in vivo,” Biomed Mater, 2014, 9:025011, 11 pgs. [cited by applicant]
Yan, et al., “Comparison of the Effects of Mg-6Zn and Titanium on Intestinal Tract in vivo,” J Mater Sci: Mater Med, 2013, 24:1515-1525, 11 pgs. [cited by applicant]
Brazilian Search Report dated Jun. 12, 2020 for Application No. BR 112018003687-0, 4 pgs. [cited by applicant]
European Search Report and Written Opinion dated Feb. 8, 2017 for Application No. EP 16185873.3, 15 pgs. [cited by applicant]
Chinese Search Report dated Apr. 8, 2020 for Application No. CN 201680062460.4, 2 pgs. [cited by applicant]
International Search Report and Written Opinion dated Nov. 3, 2016 for Application No. PCT/US2016/046316, 19 pgs. [cited by applicant]
Japanese Office Action, Notification of Reasons for Refusal, dated Jul. 21, 2020 for Application No. JP 2018-510449, 4 pgs. [cited by applicant]
Russian Search Report dated Feb. 19, 2020 for Application No. RU 2018110061, 2 pgs. [cited by applicant]
U.S. Appl. No. 12/031,573, filed Feb. 14, 2008, entitled: “Surgical Cutting and Fastening Instrument Having RF Electrodes.”. [cited by applicant]